Skip to main content

Increased Incidence of Chronic Conditions Instrumental for Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Growth

According to Inkwood Research, the Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market is predicted to record a CAGR of 20.65% in terms of revenue during the forecasting years of 2021-2028.

“Browse 49 Market Data Tables and 42 Figures spread over 167 Pages, along with an in-depth TOC on the Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Forecast 2021-2028.”

REQUEST CUSTOMIZATION LINK - https://www.inkwoodresearch.com/request-for-custom-report/

REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/

VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/#table-of-contents

BUY NOW- https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/

 

Non-alcoholic steatohepatitis (NASH) is characterized by a destructive form of non-alcoholic fatty liver disease (NAFLD). The condition often progresses to more severe disorders, including cirrhosis and hepatocellular carcinoma. As a result, NASH is likely to even surpass the hepatitis C virus infection, thereby becoming the leading cause of liver transplantation, worldwide, over the upcoming decade. 

Rising Prevalence of Chronic Diseases to Drive Market Growth

Non-alcoholic fatty liver disease (NAFLD) is a significant factor accredited to the rising incidence of liver disease, across the globe. NAFLD entails extra fat in individuals’ liver, who consume less or no alcohol. Besides, obesity and insulin resistance are among the condition’s major causes. 

On the other hand, the prevalence of alcoholic fatty liver and liver cancer cases is rapidly growing, as the number of alcoholics increase, annually. Likewise, the incidence of hepatocellular carcinoma is estimated to be 50 million, worldwide, while more than 15 million people in the United States are diagnosed with alcoholic fatty liver. Hence, the therapeutic choices available for liver cancer and alcoholic fatty liver, play an essential role in treating such diseases. 



To know more about this report, request a free sample copy.

Pharma & CRO Industry is the Leading End-User

The pharma and contract research organizations (CROs) division is anticipated to display a lucrative growth rate, over the upcoming years. The strong growth is accredited to the increased demand for non-invasive NASH diagnostic and monitoring tools in the ongoing clinical trials, particularly by CROs as well as pharmaceutical manufacturers. In addition, numerous enterprises are involved in therapeutics investigations for NASH. However, factors such as unknown etiology, complex pathophysiology, and expensive treatment for NASH, are expected to limit the segment’s revenue growth, over the forecast period. Besides, during the drug’s clinical trial, the routine monitoring of drug therapy is ideally non-invasive. This factor is projected to bolster the adoption of biomarker tests, predominantly in terms of NASH diagnostics.

North America Dominated the Global Market in 2020

The growing incidence of obesity and diabetes, the projected launch of pipeline molecules, as well as the early diagnosis of NASH are accredited to North America’s market growth. Moreover, favorable reimbursement policies within the region’s healthcare infrastructure, coupled with the easy availability of innovative therapeutics, play an essential role in augmenting the market growth.

The competitive rivalry within the global market is expected to be moderate, on account of the unavailability of treatment. Key market players concentrate on partnerships and research and development, for introducing new products into the market. 

Leading enterprises operating in the market include, Novartis AG, Pfizer Inc, Merck & Co, AstraZeneca, etc.

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us

https://www.inkwoodresearch.com

sales@inkwoodresearch.com

+1 857-302-4704

Related Reports:

GLOBAL BARIATRIC SURGERY MARKET

GLOBAL HERNIA REPAIR DEVICES AND CONSUMABLES MARKET

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET

GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Surging Chronic Conditions to Supplement Global Magnetic Resonance Imaging (MRI) Systems Market Growth

Inkwood Research anticipates that the Global Magnetic Resonance Imaging (MRI) Systems Market is evaluated to record a CAGR of 5.50% in terms of revenue during the forecasted years of 2021-2028. “Browse 53 Market Data Tables and 48 Figures spread over 229 Pages, along with an in-depth TOC on the Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2021-2028.”   BUY NOW - https://www.inkwoodresearch.com/reports/mri-systems-market/   Magnetic resonance imaging (MRI) is characterized as a non-invasive imaging technology aiming to produce detailed 3-D (three-dimensional) anatomical images. It is typically used for the detection and diagnosis of diseases, in addition to monitoring further treatment. MRI systems are based on a sophisticated technology that detects changes in the rotational axis direction of protons found in water that constitutes living tissues. Increasing Prevalence of Chronic Conditions to Augment Market Growth The four most critical types...
Post a Comment
Read more

Technological Advancements to Significantly Influence Global Stem Cell Market Growth

  According to Inkwood Research, the Global Stem Cell Market is projected to register a CAGR of 7.82% in terms of revenue during the forecasting years of 2021-2028. “Browse 93 Market Data Tables and 65 Figures spread over 286 Pages, along with an in-depth TOC on the Global Stem Cell Market Forecast 2021-2028.” REQUEST CUSTOMIZATION LINK - https://www.inkwoodresearch.com/request-for-custom-report/ REQUEST FREE SAMPLE LINK – https://www.inkwoodresearch.com/reports/stem-cell-market/#request-free-sample VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/stem-cell-market/#table-of-contents BUY NOW - https://www.inkwoodresearch.com/reports/stem-cell-market/   Stem cells harbor substantial potential, in terms of cutaneous tissue regeneration and facilitating wound repair in a paracrine manner. Numerous types of cells, such as, hematopoietic stem cells, adipose-derived stem cells, epithelial stem cells, resident tissue stem cells, embryonic stem cel...
Post a Comment
Read more

Autoimmune Diseases are the Major Driver of the Global Alopecia (Hair Loss) Treatment Market Growth

According to the estimations put forth by Inkwood Research, the Global Alopecia (Hair Loss) Treatment Market is projected to develop with a CAGR of 4.56% in terms of revenue during the forecasting years of 2021-2028. “Browse 63 Market Data Tables and 52 Figures spread over 150 Pages, along with an in-depth TOC on the Global Alopecia (Hair Loss) Treatment Market Forecast 2021-2028.” REQUEST FREE SAMPLE LINK - https://inkwoodresearch.com/reports/alopecia-hair-loss-treatment-market/#request-free-sample VIEW TABLE OF CONTENT LINK - https://inkwoodresearch.com/reports/alopecia-hair-loss-treatment-market/#table-of-contents BUY NOW - https://inkwoodresearch.com/reports/alopecia-hair-loss-treatment-market/   Alopecia is a condition that causes hair loss in small patches, which can be unnoticeable. This is because the immune system attacks the hair follicles, leading to hair loss. It affects males, females, and children. Rising Autoimmune Diseases Drive Market Growth In ...
Post a Comment
Read more